
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“ACE inhibitor use and risk of cataract: a case-control analysis”, Br J Ophthalmol, 2019.
, “Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study”, J Diabetes Complications, vol. 30, pp. 903-9, 2016.
, “Acute respiratory-tract infections and risk of first-time acute myocardial infarction”, Lancet, vol. 351, pp. 1467-71, 1998.
, “Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis”, Respir Res, vol. 19, p. 75, 2018.
, “Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer”, Arch Intern Med, vol. 160, pp. 349-53, 2000.
, “Antibiotics and risk of subsequent first-time acute myocardial infarction”, Jama, vol. 281, pp. 427-31, 1999.
, “Antibiotics in the prevention and treatment of coronary heart disease”, J Infect Dis, vol. 181 Suppl 3, pp. S558-62, 2000.
, “Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study”, J Clin Endocrinol Metab, 2020.
, “Antihypertensive drugs and the risk of incident rosacea”, Br J Dermatol, vol. 171, pp. 130-6, 2014.
, “Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders”, Travel Med Infect Dis, vol. 11, pp. 71-80, 2013.
, “Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis”, CNS Drugs, vol. 29, pp. 591-603, 2015.
, “Antiseizure drugs and risk of developing smoking-related chronic obstructive pulmonary disease or lung cancer: A population-based case-control study”, Br J Clin Pharmacol, 2020.
, “Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer”, Pharmacotherapy, vol. 22, pp. 303-9, 2002.
, “Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study”, Br J Dermatol, vol. 158, pp. 1299-307, 2008.
, “Association between body mass index and liver disorders: an epidemiological study”, J Hepatol, vol. 37, pp. 741-7, 2002.
, “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
, “The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea”, Br J Dermatol, vol. 170, pp. 878-83, 2014.
, “The association between thyroid disorders and incident gout: population-based case-control study”, Clin Epidemiol, vol. 9, pp. 205-215, 2017.
, “Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study”, J Am Acad Dermatol, vol. 58, pp. 421-9, 2008.
, “Association of hormone therapy and incident gout: population-based case-control study”, Menopause, vol. 22, pp. 1335-42, 2015.
, “Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 38, pp. 909-19, 2015.
, “Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1116-1123, 2016.
, “Bone fractures in children with autistic spectrum disorder”, J Dev Behav Pediatr, vol. 35, pp. 353-9, 2014.
, “Cancer risk in association with Parkinson disease: a population-based study”, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Chronic obstructive pulmonary disease and the risk of cardiovascular diseases”, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
, “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
, “COPD and the risk of depression”, Chest, vol. 137, pp. 341-7, 2010.
, “Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction”, Pharmacotherapy, vol. 25, pp. 503-10, 2005.
, “Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction”, Drug Saf, vol. 27, pp. 1157-65, 2004.
, “Diabetes in patients with idiopathic Parkinson's disease”, Diabetes Care, vol. 31, pp. 1808-12, 2008.
, “Diabetes mellitus and the risk of cholecystectomy”, Dig Liver Dis, vol. 43, pp. 742-7, 2011.
, “Diabetes, use of antidiabetic drugs, and the risk of glioma”, Neuro Oncol, vol. 18, pp. 340-9, 2016.
, “Diabetes, use of metformin, and the risk of meningioma”, PLoS One, vol. 12, p. e0181089, 2017.
, “Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction”, Arch Intern Med, vol. 164, pp. 2472-6, 2004.
, “Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin”, Thromb Haemost, vol. 94, pp. 537-43, 2005.
, “Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK”, Thorax, vol. 52, pp. 612-7, 1997.
, “Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis”, Respirology, vol. 17, pp. 861-8, 2012.
, “Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction”, Am J Cardiol, vol. 93, pp. 198-200, 2004.
, “Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK”, J Alzheimers Dis, vol. 35, pp. 565-73, 2013.
, “Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities”, Br J Cancer, vol. 111, pp. 203-6, 2014.
, “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK”, J Invest Dermatol, vol. 137, pp. 1240-1247, 2017.
, “HMG-CoA reductase inhibitors and the risk of fractures”, Jama, vol. 283, pp. 3205-10, 2000.
, “Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study”, Osteoarthritis Cartilage, vol. 25, pp. 1040-1045, 2017.
, “Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis”, Arthritis Care Res (Hoboken), 2018.
, “Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 801-11, 2014.
, “Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis”, Semin Arthritis Rheum, vol. 46, pp. 650-656, 2017.
, “Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008”, Respiration, vol. 84, pp. 200-6, 2012.
, “Inflammatory Bowel Disease and the Risk of Autoimmune Diseases”, J Crohns Colitis, vol. 10, pp. 186-93, 2016.
, “Influenza infections and risk of Alzheimer's disease”, Brain Behav Immun, vol. 57, pp. 187-192, 2016.
,